CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT | BSE: 524742 | ISIN: INE475E01026 | Industry: Pharmaceuticals
| Mid-range Performer

2054.6000 36.80 (1.82%)

NSE Jul 07, 2025 15:31 PM

45.92% Gain from 52W Low

Volume: 106.6K

Caplin Point Laboratories Ltd.

08 Jan 2024

2054.60

1.82%

Company Update

CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the QE December 31, 2023 is enclosed.

More from Caplin Point Laboratories Ltd.

Recommended

As IPO fever hits new high, Crizac and three other listings on the horizon

| 07 Jul 2025, 05:34PM

Market closes flat, Sharda Motor's board approves 1:1 bonus share allotment

Trendlyne Marketwatch | 07 Jul 2025, 03:55PM

Caplin Point Laboratories maintains export momentum, expands ambitions to new markets